GEOG 2002: Geographies of Global Change: Spring 2004
 
Instructor: Professor John O'Loughlin

Home |  Syllabus |  Course Materials |  Electronic Reserves |  Paper Guidelines |  Paper Submission |  Sample Exam |  Debates |  Links |  Geography |  Contact

 

Debate 4

Tackling AIDS in Africa

 

The fourth debate in week 13 of the class will focus on the prospects for the control and reduction of the AIDS epidemic in Africa. While AIDS in the rich West is now treated with combinations of expensive drugs and campaigns to reduce risky behaviors that contribute to the spread of AIDS, AIDS continues to wreck social, economic and health havoc, especially in southern Africa. The Economist states that AIDS is the "most political disease around," killing more people (19 million) than died in World War I. Our discussion will focus on the debates about Africa, involving the major global economic institutions, international organizations and the big pharmaceutical companies now beginning to develop, test and market drugs for the effective treatment of AIDS.  The article presents some startling figures on the impact of AIDS on the demographic profile of Africa, especially the dramatic rise in the number of orphans. Note the shift in the Botswana age-sex pyramid from a classic pyramid to a chimney outline to 2020. Unlike the West, where the disease is concentrated in certain high-risk groups, AIDS in Africa reaches into all populations. But importantly, there are major geographic differences within Sub-Saharan Africa, with West Africa having generally lower rates of HIV infection and of AIDS. How much of the difference is attributable to different cultural practices (under what conditions and across which groups does sexual intercourse occur) or differential governmental efforts to slow the spread of the disease (such as condom promotion), is still an open question.  Finally, outsiders are beginning to pay attention, making the case that the AIDS epidemic in Africa is not just a health crisis but is now extended to issues of national security. On the one hand, outside interest and health spending is welcomed by Africans but on the other hand, many governments have been silent on the subject and resent the loss of autonomy implied by the usurpation of the AIDS prevention programs by international agencies. Most African governments have been especially reluctant to empower women who are the silent victims of the epidemic. (For an evocative account of the destruction by AIDS of women’s’ lives in Malawi, see the article by Maggie O’Kane, the award-winning Irish journalist for the Guardian, one of Britain’s quality newspapers.)  The Economist makes the point that there is hope amid the gloom of the crisis but successful efforts will require a coordinated effort to a) make effective drugs, such as AZT and nevirapine, available to those who need them at no or very low cost; b) to enlist the support of governments who will promote safe sex practices, including widespread use of condoms; c) to empower and educate women and girls to challenge traditional male-dominated sexual practices; and d) to learn from the experience of those countries, such as Uganda or Senegal, who have reversed the AIDS tidal wave. Begin research for this debate by reading the Economist article on electronic reserve titled "AIDS – A Mixed Prognosis."  

Team A

GlaxoSmithKline

 

A huge multi-national pharmaceutical company making drugs to combat AIDS: see the GlaxoSmithKline Company website (search for AIDS related articles in this site).

 

Team B

United Nations  (UNAIDS)

 

The United Nations coordinates the world-wide effort to combat AIDS.

 

Team C

Society of Women Against AIDS in Africa

 

An international NGO dedicated to empowering women to change their status vis-à-vis risk of AIDS: see the SWAA website and related discussions of their objectives. 

 

Team D

South African Ministry of Health

The South African Ministry of Health is a frontline governmental agency late in getting started on health awareness. 

Team E

International AIDS Vaccine Initiative

 

The International AIDS Vaccine Initiative is a charity dedicated to raising money for AIDS vaccine research, patenting the rights and distributing the vaccine at low cost. 

 

Questions for the debate to address:

  1. How serious is the AIDS crisis in Africa? Is it exaggerated in the media accounts?
  2. What has caused the AIDS epidemic in Africa to be markedly worse than in other regions of the world?
  3. What are the most effective programs to combat the AIDS epidemic in Africa? Why?
  4. Can successful practices in one country be transferred to another setting? If not, why not?